Zentek (TSE:ZEN) has released an update.
Zentek’s subsidiary, Triera Biosciences, has secured a $1.1 million contract from the Government of Canada to test its innovative multivalent aptamer technology. This funding will support the development of rapid drug discovery solutions for highly pathogenic avian influenza, showcasing the government’s commitment to advancing the life sciences sector in Canada.
For further insights into TSE:ZEN stock, check out TipRanks’ Stock Analysis page.
